Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Chem Commun (Camb) ; 59(89): 13348-13351, 2023 Nov 07.
Article in English | MEDLINE | ID: mdl-37872783

ABSTRACT

A TTPP probe was developed to distinguish G-quadruplexes (G4s) from other nucleic acid topologies through longer fluorescence lifetimes and higher quantum yields. In fluorescence lifetime imaging microscopy, TTPP enabled the visualization of cytoplasmic G4s in live cells, and showed the potential to detect cell apoptosis and ferroptosis by tracking cytoplasmic G4s.


Subject(s)
G-Quadruplexes , Nucleic Acids , Fluorescent Dyes , Cytoplasm , Cytosol
2.
Angew Chem Int Ed Engl ; 59(42): 18755-18762, 2020 10 12.
Article in English | MEDLINE | ID: mdl-32634290

ABSTRACT

The development and malignancy of cancer cells are closely related to the changes of the epigenome. In this work, a mitochondria-targeted rhenium(I) complex (DFX-Re3), integrating the clinical iron chelating agent deferasirox (DFX), has been designed. By relocating iron to the mitochondria and changing the key metabolic species related to epigenetic modifications, DFX-Re3 can elevate the methylation levels of histone, DNA, and RNA. As a consequence, DFX-Re3 affects the events related to apoptosis, RNA polymerases, and T-cell receptor signaling pathways. Finally, it is shown that DFX-Re3 induces immunogenic apoptotic cell death and exhibits potent antitumor activity in vivo. This study provides a new approach for the design of novel epigenetic drugs that can recode the cancer epigenome by intervening in mitochondrial metabolism and iron homeostasis.


Subject(s)
Coordination Complexes/chemistry , Iron/metabolism , Mitochondria/metabolism , Rhenium/chemistry , Animals , Apoptosis/drug effects , Cell Line, Tumor , Coordination Complexes/pharmacology , Coordination Complexes/therapeutic use , Deferasirox/chemistry , Drug Evaluation, Preclinical , Epigenomics , Histones/metabolism , Humans , Iron Chelating Agents/chemistry , Methylation/drug effects , Mice , Mitochondria/drug effects , Neoplasms/drug therapy , Neoplasms/metabolism , Neoplasms/pathology , RNA Polymerase II/metabolism , Reactive Oxygen Species/metabolism , Receptors, Antigen, T-Cell/metabolism , Signal Transduction/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...